Literature DB >> 8120456

Histaminergic regulation of antibody-dependent cellular cytotoxicity of granulocytes, monocytes, and natural killer cells.

K Hellstrand1, A Asea, S Hermodsson.   

Abstract

We investigated effects of the biogenic diamine histamine on antibody-dependent cellular cytotoxicity (ADCC) against autologous anti-D-coated red blood cells mediated by human granulocytes, monocytes, and natural killer (NK) cells. Effector cells were separated from peripheral blood by countercurrent centrifugal elutriation. ADCC of monocytes and neutrophilic granulocytes was suppressed by histamine. ADCC of enriched CD3-/56+ NK cells was unchanged by histamine. ADCC of NK cells was effectively inhibited by elutriated monocytes or neutrophils. Histamine completely reversed the inhibition of NK cell-mediated ADCC induced by monocytes and partly reversed the inhibition induced by neutrophils; thereby, histamine augmented ADCC of NK cells in the presence of monocytes or neutrophils. The indirect effect of histamine on ADCC of NK cells and the effect of histamine on ADCC of monocytes/neutrophils were completely antagonized by the specific H2 receptor (H2R) blocker ranitidine. We conclude that activation of H2R suppresses ADCC reactivity of monocytes/neutrophils and, concomitantly, promotes ADCC reactivity of NK cells by abrogating a phagocyte-derived, suppressive signal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8120456     DOI: 10.1002/jlb.55.3.392

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

Review 1.  Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists.

Authors:  A A Fisher; D G Le Couteur
Journal:  Drug Saf       Date:  2001-01       Impact factor: 5.606

2.  Role of histamine in natural killer cell-dependent protection against herpes simplex virus type 2 infection in mice.

Authors:  K Hellstrand; A Asea; S Hermodsson
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

3.  Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinoma.

Authors:  F Donskov; M Middleton; K Fode; P Meldgaard; W Mansoor; J Lawrance; N Thatcher; H Nellemann; H von der Maase
Journal:  Br J Cancer       Date:  2005-10-03       Impact factor: 7.640

Review 4.  Mast Cells: A New Frontier for Cancer Immunotherapy.

Authors:  Jake N Lichterman; Sangeetha M Reddy
Journal:  Cells       Date:  2021-05-21       Impact factor: 6.600

5.  Role of the ERK pathway for oxidant-induced parthanatos in human lymphocytes.

Authors:  Ali A Akhiani; Olle Werlenius; Johan Aurelius; Charlotta Movitz; Anna Martner; Kristoffer Hellstrand; Fredrik B Thorén
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.